US Patent Issued to AFFILIATED HOSPITAL OF NANTONG UNIVERSITY on Nov. 3 for "Use of TMED8 gene in preparation of drug and diagnostic kit for pancreatic cancer" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,283, issued on Nov. 3, was assigned to AFFILIATED HOSPITAL OF NANTONG UNIVERSITY (Nantong, China).

"Use of TMED8 gene in preparation of drug and diagnostic kit for pancreatic cancer" was invented by Mingbing Xiao (Nantong, China), Tong Wu (Nantong, China), Xingjuan Fan (Nantong, China), Jiahai Shi (Nantong, China), Wenjie Zheng (Nantong, China), Wenkai Ni (Nantong, China), Chengqi Guan (Nantong, China) and Ziwei Chen (Nantong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides use of a transmembrane emp24 domain 8 (TMED8) gene in preparation of a drug and a diagnostic kit for pancreatic cancer, and belongs to the tec...